oral administration

Summary

Summary: The giving of drugs, chemicals, or other substances by mouth.

Top Publications

  1. ncbi Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study
    Saverio Bettuzzi
    Department of Medicina Sperimentale, Sezione di Biochimica, University of Parma, Via Volturno 39, 43100 Parma, Italy
    Cancer Res 66:1234-40. 2006
  2. ncbi Oral administration of a GSK3 inhibitor increases brain insulin-like growth factor I levels
    Marta Bolos
    Cajal Institute, Consejo Superior de Investigaciones Cientificas, and CIBERNED, Madrid 28002, Spain
    J Biol Chem 285:17693-700. 2010
  3. ncbi Bosentan therapy for pulmonary arterial hypertension
    Lewis J Rubin
    Division of Pulmonary and Critical Care Medicine, University of California at San Diego, La Jolla 92037 1330, USA
    N Engl J Med 346:896-903. 2002
  4. ncbi Daily oral administration of crocetin attenuates physical fatigue in human subjects
    Hiroshi Mizuma
    Department of Physiology, Osaka City University Graduate School of Medicine, Osaka 545 8585, Japan
    Nutr Res 29:145-50. 2009
  5. ncbi Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performance
    Mari Carmen Gomez-Cabrera
    Department of Physiology, Faculty of Medicine, University of Valencia, Valencia, Spain
    Am J Clin Nutr 87:142-9. 2008
  6. ncbi Exposure to oral bisphosphonates and risk of esophageal cancer
    Chris R Cardwell
    Centre for Public Health, Queen s University Belfast, Grosvenor Rd, Belfast BT12 6BJ, United Kingdom
    JAMA 304:657-63. 2010
  7. ncbi The distribution and accumulation of fucoxanthin and its metabolites after oral administration in mice
    Takashi Hashimoto
    Graduate School of Agricultural Science, Kobe University, 1 1 Rokkodai, Nada, Kobe, Hyogo 657 8501, Japan
    Br J Nutr 102:242-8. 2009
  8. ncbi Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization
    Christophe P Frossard
    University Hospital of Geneva, Department of Pediatrics, Geneva, Switzerland
    J Allergy Clin Immunol 119:952-9. 2007
  9. ncbi Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir
    S Bantia
    BioCryst Pharmaceuticals, Inc, Birmingham, Alabama 35244, USA
    Antimicrob Agents Chemother 45:1162-7. 2001
  10. ncbi Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo
    G Mittal
    Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, S A S Nagar, Punjab, India
    J Control Release 119:77-85. 2007

Detail Information

Publications264 found, 100 shown here

  1. ncbi Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study
    Saverio Bettuzzi
    Department of Medicina Sperimentale, Sezione di Biochimica, University of Parma, Via Volturno 39, 43100 Parma, Italy
    Cancer Res 66:1234-40. 2006
    ..As a secondary observation, administration of GTCs also reduced lower urinary tract symptoms, suggesting that these compounds might also be of help for treating the symptoms of benign prostate hyperplasia...
  2. ncbi Oral administration of a GSK3 inhibitor increases brain insulin-like growth factor I levels
    Marta Bolos
    Cajal Institute, Consejo Superior de Investigaciones Cientificas, and CIBERNED, Madrid 28002, Spain
    J Biol Chem 285:17693-700. 2010
    ..Notably, oral administration of a GSK3 inhibitor to adult wild-type mice or to amyloid precursor protein/presenilin 1 mice modeling ..
  3. ncbi Bosentan therapy for pulmonary arterial hypertension
    Lewis J Rubin
    Division of Pulmonary and Critical Care Medicine, University of California at San Diego, La Jolla 92037 1330, USA
    N Engl J Med 346:896-903. 2002
    ..The present trial investigated the effect of bosentan on exercise capacity in a larger number of patients and compared two doses...
  4. ncbi Daily oral administration of crocetin attenuates physical fatigue in human subjects
    Hiroshi Mizuma
    Department of Physiology, Osaka City University Graduate School of Medicine, Osaka 545 8585, Japan
    Nutr Res 29:145-50. 2009
    ..3-way crossover study, 14 Japanese healthy volunteers (7 men and 7 women) were randomized to oral administration of crocetin (15 mg), ascorbic acid (3,000 mg), or placebo for 8 days...
  5. ncbi Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performance
    Mari Carmen Gomez-Cabrera
    Department of Physiology, Faculty of Medicine, University of Valencia, Valencia, Spain
    Am J Clin Nutr 87:142-9. 2008
    ..There is, however, considerable debate regarding the beneficial health effects of vitamin C supplementation...
  6. ncbi Exposure to oral bisphosphonates and risk of esophageal cancer
    Chris R Cardwell
    Centre for Public Health, Queen s University Belfast, Grosvenor Rd, Belfast BT12 6BJ, United Kingdom
    JAMA 304:657-63. 2010
    ..Esophagitis is a known adverse effect of bisphosphonate use, and recent reports suggest a link between bisphosphonate use and esophageal cancer, but this has not been robustly investigated...
  7. ncbi The distribution and accumulation of fucoxanthin and its metabolites after oral administration in mice
    Takashi Hashimoto
    Graduate School of Agricultural Science, Kobe University, 1 1 Rokkodai, Nada, Kobe, Hyogo 657 8501, Japan
    Br J Nutr 102:242-8. 2009
    ..In a single oral administration of 160 nmol fucoxanthin, fucoxanthinol and amarouciaxanthin A were detectable in all specimens tested in ..
  8. ncbi Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization
    Christophe P Frossard
    University Hospital of Geneva, Department of Pediatrics, Geneva, Switzerland
    J Allergy Clin Immunol 119:952-9. 2007
    ..Because tolerance to food is potentially modulated by IL-10, strategies to prevent food allergy should favor an increased delivery of IL-10 to the gut...
  9. ncbi Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir
    S Bantia
    BioCryst Pharmaceuticals, Inc, Birmingham, Alabama 35244, USA
    Antimicrob Agents Chemother 45:1162-7. 2001
    ..b>Oral administration of a dosage of 1 mg/kg of body weight/day of RWJ-270201 for 5 days (beginning 4 h preinfection) showed ..
  10. ncbi Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo
    G Mittal
    Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, S A S Nagar, Punjab, India
    J Control Release 119:77-85. 2007
    ..Together, these results indicate that nanoparticulate formulations are ideal carriers for oral administration of estradiol having great potential to address the dose related issues of estradiol.
  11. ncbi Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Can
    W V Kern
    Sektion Infektiologie und Klinische Immunologie, Medizinische Universitätsklinik und Poliklinik, Ulm, Germany
    N Engl J Med 341:312-8. 1999
    ..If orally administered empirical therapy is as effective as intravenous therapy, it would offer advantages such as improved quality of life and lower cost...
  12. ncbi Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice
    Sergio Rodriguez-Cuenca
    Department of Clinical Biochemistry, University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Cambridge CB2 0QQ, UK
    Free Radic Biol Med 48:161-72. 2010
    ..Therefore, MitoQ does not act as a pro-oxidant in vivo. These findings indicate that mitochondria-targeted antioxidants can be safely administered long-term to wild-type mice...
  13. ncbi Synapse formation is enhanced by oral administration of uridine and DHA, the circulating precursors of brain phosphatides
    R J Wurtman
    Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
    J Nutr Health Aging 13:189-97. 2009
    ....
  14. ncbi The reformulation of amphotericin B for oral administration to treat systemic fungal infections and visceral leishmaniasis
    Sheila J Thornton
    Division of Pharmaceutics and Biopharmaceutics, The University of British Columbia, 2146 East Mall, Vancouver, BC, V6T 1Z3, Canada
    Expert Opin Drug Deliv 6:271-84. 2009
    ....
  15. ncbi Decrease in plasma concentrations of antiangiogenic agent TSU-68 ((Z)-5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid) during oral administration twice a day to rats
    Ryuichi Kitamura
    Pharmacokinetics Research Laboratory, Taiho Pharmaceutical Co, Ltd, 224 2, Ebisuno, Hiraishi, Kawauchicho, Tokushima 771 0194, Japan
    Drug Metab Dispos 35:1611-6. 2007
    ..Plasma clearance of TSU-68 intravenously administered 12 h after oral administration was 1...
  16. ncbi Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects
    F I Kanaze
    Department of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, Greece
    Eur J Clin Nutr 61:472-7. 2007
    ..is available on the pharmacokinetics of the citrus flavanones hesperetin and naringenin after their oral administration to humans as pure aglycones...
  17. ncbi Cucurbitacin B induces apoptosis and S phase cell cycle arrest in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration
    Kin Tak Chan
    Department of Technology and Product Development, CK Life Sciences Int l, Holdings Inc, 2 Dai Fu Street, Tai Po Industrial Estate, Hong Kong SAR, China
    Cancer Lett 294:118-24. 2010
    ..Moreover, in vivo study demonstrated that cucurbitacin B is effective against BEL-7402 xenograft when administrated orally...
  18. ncbi Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic
    W Wolfgang Fleischhacker
    Department of Biological Psychiatry, Innsbruck University Clinics, Anichstrasse 35, 6020 Innsbruck, Austria
    J Clin Psychiatry 64:1250-7. 2003
    ..The long-term safety and efficacy of long-acting injectable risperidone, the first long-acting second-generation antipsychotic, were evaluated in stable patients with schizophrenia...
  19. ncbi Pharmacokinetics and pharmacodynamics of a new ACT formulation: Artesunate/Amodiaquine (TRIMALACT) following oral administration in African malaria patients
    V Sinou
    UMR MD3, Faculty of Pharmacy, University of Mediterranee, Institute of Tropical Medicine of the French Army Forces, Marseille, France
    Eur J Drug Metab Pharmacokinet 34:133-42. 2009
    ..48% carrying parasite with the CQ-resistant haplotype. This study shows that the AS/AQ combination TRIMALACT is safe and effective in the treatment of highly drug-resistant falciparum malaria...
  20. ncbi Intestinal and immunological effects of daily oral administration of Lactobacillus salivarius CECT5713 to healthy adults
    Saleta Sierra
    Nutrition and Health Department, Puleva Biotech SA, Camino de Purchil 66, 18004 Granada, Spain
    Anaerobe 16:195-200. 2010
    ..27.3+/-6.4 pg/mL in control group, P<0.01). Thus, it can be concluded that daily administration of L. salivarius CECT5713 to healthy adults is safe and improve gut microbiota and different parameters related to immune response...
  21. ncbi In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate
    Wolfgang Wienen
    Department of Pulmonary Research, Boehringer Ingelheim Pharma GmbH and Co KG, Birkendorfer Strasse, 88397 Biberach, Germany
    Thromb Haemost 98:155-62. 2007
    ..These data suggest that dabigatran is a potent, selective thrombin inhibitor and an orally active anticoagulant as the prodrug, dabigatran etexilate...
  22. ncbi Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis
    Sarah Perkins
    Cancer Biomarkers and Prevention Group, Department of Oncology, University of Leicester, Leicester, United Kingdom
    Cancer Epidemiol Biomarkers Prev 11:535-40. 2002
    ..6 g of curcumin is required for efficacy in humans. A clear advantage of curcumin over nonsteroidal anti-inflammatory drugs is its ability to decrease intestinal bleeding linked to adenoma maturation...
  23. ncbi Novel 4-anilinoquinazolines with C-7 basic side chains: design and structure activity relationship of a series of potent, orally active, VEGF receptor tyrosine kinase inhibitors
    Laurent F Hennequin
    AstraZeneca, Centre de Recherches, Z I la Pompelle, B P 1050, Chemin de Vrilly, 51689 Reims, Cedex 2, France
    J Med Chem 45:1300-12. 2002
    ..b>Oral administration of representative compounds to mice (50 mg/kg) produced plasma levels between 0...
  24. ncbi Liquid chromatography tandem mass spectrometry identification of proanthocyanidins in rat plasma after oral administration of grape seed extract
    Jeevan K Prasain
    Department of Pharmacology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
    Phytomedicine 16:233-43. 2009
    ..Using LC-MS/MS, (+)-catechin and (-)-epicatechin were identified in the brain conclusively. These data suggested that GSE catechins cross the blood brain barrier and may be responsible for the neuroprotective effects of GSE...
  25. ncbi Oral administration of beta-cryptoxanthin prevents bone loss in ovariectomized rats
    Satoshi Uchiyama
    Laboratory of Endocrinology and Molecular Metabolism, Graduate School of Nutritional Sciences, University of Shizuoka, Shizuoka 422-8526, Japan
    Int J Mol Med 17:15-20. 2006
    ..These decreases were significantly prevented by the administration of beta-cryptoxanthin (5 or 10 microg/100 g). This study demonstrates that beta-cryptoxanthin has a preventive effect on OVX-induced bone loss in vivo...
  26. ncbi Double-coated poly (butylcynanoacrylate) nanoparticulate delivery systems for brain targeting of dalargin via oral administration
    Debanjan Das
    College of Pharmacy and Allied Health Professions, St. John's University, Jamaica, NY 11439, USA
    J Pharm Sci 94:1343-53. 2005
    The aim of this study is to evaluate oral administration of poly (butylcyanoacrylate) nanoparticulate delivery systems (PBCA-NDSs), double-coated with Tween 80 and poly (ethylene) glycol (PEG) 20000 for brain delivery of hexapeptide ..
  27. ncbi Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy
    Marc A Rodger
    Thrombosis Program, Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, Ont
    CMAJ 179:417-26. 2008
    ..We sought to determine clinical predictors to identify patients who are at low risk of recurrent venous thromboembolism who could safely discontinue oral anticoagulants...
  28. ncbi Oral administration of GW788388, an inhibitor of TGF-beta type I and II receptor kinases, decreases renal fibrosis
    M Petersen
    Department of Molecular Cell Biology, Leiden University Medical Centre, Leiden, The Netherlands
    Kidney Int 73:705-15. 2008
    ..Our study shows that GW788388 is a potent and selective inhibitor of TGF-beta signalling in vitro and renal fibrosis in vivo...
  29. ncbi Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogs
    Shui-Mei Khoo
    Department of Pharmaceutics, Victorian College of Pharmacy, Monash University, Parkville, Victoria 3052, Australia
    Pharm Res 20:1460-5. 2003
    ..Furthermore, microemulsions based on long-chain glycerides appear to be more effective with respect to lymphatic transport than the equivalent medium-chain formulation...
  30. ncbi HPLC determination and pharmacokinetic studies of salvianolic acid B in rat plasma after oral administration of Radix Salviae Miltiorrhizae extract
    Jinlan Zhang
    School of Pharmaceutical Sciences and Modern Research Center for Traditional Chinese Medicine, Peking University, Beijing 100083, People's Republic of China
    Biomed Chromatogr 19:15-8. 2005
    ..has been established and validated for determination of salvianolic acid B (SalB) in rat plasma after oral administration of Radix Salviae Miltiorrhizae extract. Liquid-liquid extraction was adopted for the sample preparation...
  31. ncbi Comparative effect of oral administration and topical application of alcoholic extract of Terminalia arjuna bark on incision and excision wounds in rats
    Madhura M Rane
    CU Shah College of Pharmacy, SNDT Women's University, Santacruz-west, Mumbai, Maharashtra 400 049, India
    Fitoterapia 74:553-8. 2003
    ..The estimated increase in hydroxyproline content of the granulation tissue of the excision wounds indicated rapid collagen turnover thus, leading to rapid healing of the wounds...
  32. ncbi Threshold mechanisms and site specificity in chromium(VI) carcinogenesis
    S De Flora
    Department of Health Sciences, Section of Hygiene and Preventive Medicine, University of Genoa, Via A Pastore 1, I 16132 Genoa, Italy
    Carcinogenesis 21:533-41. 2000
    ..All experimental and epidemiological data, and the underlying mechanisms, point to the occurrence of thresholds in chromium(VI) carcinogenesis...
  33. ncbi Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates
    K E Habib
    Clinical Neuroendocrinology Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892 1284, USA
    Proc Natl Acad Sci U S A 97:6079-84. 2000
    ..After oral administration, significant antalarmin concentrations were detected in the systemic circulation and the cerebrospinal ..
  34. ncbi Oral administration of dimethylarsinic acid, a main metabolite of inorganic arsenic, in mice promotes skin tumorigenesis initiated by dimethylbenz(a)anthracene with or without ultraviolet B as a promoter
    K Yamanaka
    College of Pharmacy, Nihon University, Funabashi, Chiba, Japan
    Biol Pharm Bull 24:510-4. 2001
    ..We also discussed the involvement of a reactive oxygen species (ROS), e.g., the dimethylarsenic peroxy radical [(CH3)2AsOO.], produced during the metabolic processing of DMA, in skin and in multi-organ tumorigenesis...
  35. ncbi The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
    Matthew C Riddle
    Oregon Health and Science University, Portland, Oregon 97201, USA
    Diabetes Care 26:3080-6. 2003
    ..To compare the abilities and associated hypoglycemia risks of insulin glargine and human NPH insulin added to oral therapy of type 2 diabetes to achieve 7% HbA(1c)...
  36. ncbi Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types
    J Baselga
    Vall d Hebron University Hospital, Barcelona, Spain
    J Clin Oncol 20:4292-302. 2002
    ....
  37. ncbi The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects
    Joachim Stangier
    Boehringer Ingelheim Pharma GmbH and Co KG, Ingelheim, Germany
    Br J Clin Pharmacol 64:292-303. 2007
    ..Two double-blind, randomized trials were undertaken to investigate the pharmacokinetics (PK), pharmacodynamics (PD) and tolerability of orally administered dabigatran etexilate in healthy male subjects...
  38. ncbi Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression
    Kiichiro Beppu
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Natl Cancer Inst 96:46-55. 2004
    ..001). CONCLUSIONS: Imatinib inhibited the growth of neuroblastoma cells in vitro and in vivo. This inhibition was associated with suppression of PDGFR and c-Kit phosphorylation and inhibition of VEGF expression...
  39. ncbi Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats
    T Shirasaka
    Institute for Pathogenic Biochemistry in Medicine, Taiho Pharmaceutical Co, Ltd, Saitama, Japan
    Cancer Res 53:4004-9. 1993
    ..These findings suggest that coadministration of oxonic acid suppresses the GI toxicity of 5-FU and its derivatives without affecting their antitumor activity and thus prolongs the life span of cancer-bearing rats...
  40. ncbi Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial
    Joshua Burns
    Discipline of Paediatrics and Child Health, Faculty of Medicine, University of Sydney, and Institute for Neuromuscular Research, Children s Hospital at Westmead, Sydney, NSW, Australia
    Lancet Neurol 8:537-44. 2009
    ..We tested the efficacy and safety of ascorbic acid supplementation in children with CMT1A...
  41. ncbi A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats
    Takefumi Itoh
    Department of Internal Medicine, National Cardiovascular Center, Suita, Osaka, Japan
    Am J Respir Crit Care Med 169:34-8. 2004
    ..These results suggest that combination therapy with oral sildenafil and beraprost attenuates the development of MCT-induced pulmonary hypertension compared with treatment with each drug alone...
  42. ncbi Oral cholera vaccines: use in clinical practice
    David R Hill
    National Travel Health Network and Centre, London, UK
    Lancet Infect Dis 6:361-73. 2006
    ..The vaccine can be expected to prevent 7% or less of cases of travellers' diarrhoea and should not be used for this purpose...
  43. ncbi Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): an oral, direct factor Xa inhibitor
    Susanne Roehrig
    Bayer HealthCare AG, D 42096 Wuppertal, Germany
    J Med Chem 48:5900-8. 2005
    ..Compound 5 is currently under clinical development for the prevention and treatment of thromboembolic diseases...
  44. ncbi Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A
    M H El-Shabouri
    Department of Pharmaceutics, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt
    Int J Pharm 249:101-8. 2002
    ..The relative bioavailability of Cy-A from chitosan-nanoparticles was increased by about 73%, and by about 18% from gelatin nanoparticles, while it was decreased by about 36% from SGC-nanoparticles...
  45. ncbi Comparative pharmacokinetics and effect kinetics of orally administered artesunate in healthy volunteers and patients with uncomplicated falciparum malaria
    P Teja-Isavadharm
    Department of Immunology and Medicine, US Army Component, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    Am J Trop Med Hyg 65:717-21. 2001
    ..13+/-0.52 hr, respectively (P > 0.5). Both drug metabolism and tissue protein binding could contribute to the differences between the antimalarial activity of artemisinin drugs in healthy volunteers and malaria infected patients...
  46. ncbi Different effects of SLCO1B1 polymorphism on the pharmacokinetics of atorvastatin and rosuvastatin
    M K Pasanen
    Department of Clinical Pharmacology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland
    Clin Pharmacol Ther 82:726-33. 2007
    ..521CC genotype than in those with the c.521TT genotype. These results indicate that, unexpectedly, SLCO1B1 polymorphism has a larger effect on the AUC of atorvastatin than on the more hydrophilic rosuvastatin...
  47. ncbi Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus
    Julia B Zella
    Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706, USA
    Arch Biochem Biophys 417:77-80. 2003
    ..Our results indicate that vitamin D status is a determining factor of disease susceptibility and oral administration of 1,25(OH)(2)D(3) prevents diabetes onset in NOD mice through 200 days of age.
  48. ncbi Lactobacillus casei suppresses experimental arthritis by down-regulating T helper 1 effector functions
    Jae Seon So
    Department of Life Sciences, Gwangju Institute of Science and Technology, 1 Oryong dong, Buk Gu, Gwangju 500 712, Republic of Korea
    Mol Immunol 45:2690-9. 2008
    ..b>Oral administration of L...
  49. ncbi Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial
    Gerald Simonneau
    Service de Pneumologie, Hopital Antoine Beclere, Universite Paris Sud, Clamart, France
    Ann Intern Med 149:521-30. 2008
    ..Oral sildenafil and intravenous epoprostenol have independently been shown to be effective in patients with pulmonary arterial hypertension...
  50. ncbi Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice
    Joshua D Lambert
    Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA
    J Nutr 133:4172-7. 2003
    ..This is the first report of the pharmacokinetic parameters of EGCG in mice. Such information provides a basis for understanding the bioavailability of EGCG in mice and should aid in understanding the cancer preventive activity of EGCG...
  51. ncbi Oral administration of a live attenuated Salmonella vaccine strain expressing the VapA protein induces protection against infection by Rhodococcus equi
    Aline F Oliveira
    Departamento de Biologia Celular e Molecular e Bioagentes Patogênicos, Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Av Bandeirantes, 3900, 14049 900, Ribeirao Preto, Sao Paulo, Brazil
    Microbes Infect 9:382-90. 2007
    ..Our results suggest that attenuated Salmonella encoding VapA may be used in foals to prevent rhodococcosis...
  52. ncbi Pharmacokinetics and targeting property of TFu-loaded liposomes with different sizes after intravenous and oral administration
    Weitong Sun
    The Pharmaceutical College, Shandong University, Ji Nan, PR China
    J Drug Target 16:357-65. 2008
    ..v. or oral administration to mice...
  53. ncbi A semiphysiological pharmacokinetic model for artemisinin in healthy subjects incorporating autoinduction of metabolism and saturable first-pass hepatic extraction
    Toufigh Gordi
    Division of Pharmacokinetics and Drug Therapy, Uppsala University, Uppsala, Sweden
    Br J Clin Pharmacol 59:189-98. 2005
    ..The aim of this study was to characterize the time-dependent pharmacokinetics of artemisinin in healthy subjects...
  54. ncbi Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men
    Y Nishida
    Department of Clinical Nutrition, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima, Japan
    Kidney Int 70:2141-7. 2006
    ..We conclude that oral Pi loading cannot rapidly increase serum FGF23 level. FGF23 may be not associated with rapid adaptation of Pi homeostasis...
  55. ncbi Oral administration of OKT3 monoclonal antibody to human subjects induces a dose-dependent immunologic effect in T cells and dendritic cells
    Yaron Ilan
    Center for Neurologic Diseases, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    J Clin Immunol 30:167-77. 2010
    ..b>Oral administration of anti-CD3 has not been tested in humans, but suppresses autoimmunity in animal models...
  56. ncbi Low-dose cortisol for symptoms of posttraumatic stress disorder
    Amanda Aerni
    Division of Psychiatry Research, University of Zurich, Lenggstr. 31, 8029 Zurich, Switzerland
    Am J Psychiatry 161:1488-90. 2004
    ..CONCLUSIONS: The results of this pilot study indicate that low-dose cortisol treatment reduces the cardinal symptoms of PTSD...
  57. ncbi Human papillomavirus type 16 E6-specific antitumor immunity is induced by oral administration of HPV16 E6-expressing Lactobacillus casei in C57BL/6 mice
    Tae Young Lee
    Viral Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejon, Korea
    Cancer Immunol Immunother 59:1727-37. 2010
    ..casei) and investigated E6-specific CMI following oral administration of the L. casei-PgsA-E6 to mice...
  58. ncbi Oral administration of xanthan gum enhances antitumor activity through Toll-like receptor 4
    Ario Takeuchi
    Division of Host Defense, Research Center for Prevention of Infectious Disease, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812 8582, Japan
    Int Immunopharmacol 9:1562-7. 2009
    ..Xanthan gum (XG) is a complex exopolysaccharide produced by the plant-pathogenic bacterium Xanthomonas campestris pv. and is widely used as a thickener or viscosifier. We examined in this study the antitumor effects of XG...
  59. ncbi Innate CD4+CD25+ regulatory T cells are required for oral tolerance and inhibition of CD8+ T cells mediating skin inflammation
    Bertrand Dubois
    Department de Immunité, Institut National de la Santé et de la Recherche Médicale U404, Institut Fédératif de Recherche, 128 Bioscience Lyon Gerland, 21 Avenue Tony Garnier, 69365 Lyon Cedex 07, France
    Blood 102:3295-301. 2003
    ..These data show that naturally occurring CD4+CD25+ T cells are instrumental for orally induced tolerance and are key actors for the control of antigen-specific CD8+ T-cell effectors mediating skin inflammation...
  60. ncbi Drug distribution in man: a positron emission tomography study after oral administration of the labelled neuroprotective drug vinpocetine
    Balazs Gulyas
    Department of Clinical Neuroscience, Psychiatry Section, Karolinska Hospital, 171 77 Stockholm, Sweden
    Eur J Nucl Med Mol Imaging 29:1031-8. 2002
    ..drug widely used in the prevention and treatment of cerebrovascular diseases, was followed after oral administration. Vinpocetine was labelled with carbon-11 and radioactivity was measured by PET in stomach, liver, brain and ..
  61. ncbi Nucleotide analogue prodrug tenofovir disoproxil enhances lymphoid cell loading following oral administration in monkeys
    Lucie Durand-Gasselin
    Gilead Sciences, Inc, Foster City, California 94404, USA
    Mol Pharm 6:1145-51. 2009
    ..In order to determine whether oral administration of TDF also increases distribution to sites of viral infection, the plasma and circulating lymphoid cell ..
  62. ncbi Oral administration of dehydroepiandrosterone-sulfate (DHEAS) increases in vitro lymphocyte function and improves in vivo response of pigs to immunization against keyhole limpet hemocyanin (KLH) and ovalbumin
    N C Burdick
    Department of Animal and Wildlife Sciences, Texas A and M University Kingsville, Kingsville, TX 78363, USA
    Int Immunopharmacol 9:1342-6. 2009
    The present study tested the hypothesis that the oral administration of DHEAS enhances the in vitro and the in vivo immune response of young pigs...
  63. ncbi Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis
    Carl van Walraven
    Clinical Epidemiology Unit, Ottawa Health Research Institute, F 6, Ottawa Hospital, Civic Campus, 1053 Carling Ave, Ottawa, Ontario, Canada K1Y 4E9
    JAMA 288:2441-8. 2002
    ..Patients with nonvalvular atrial fibrillation (AF) have an increased risk of stroke and other vascular events...
  64. ncbi Oral administration of Yokukansan inhibits the development of atopic dermatitis-like lesions in isolated NC/Nga mice
    Ju Jiang
    Atopy Allergy Research Center, Juntendo University School of Medicine, 2 1 1 Hongo, Bunkyo ku, 113 8421 Tokyo, Japan
    J Dermatol Sci 56:37-42. 2009
    ..Therefore, in the present study it was investigated whether or not YKS was effective in the treatment of AD using socially isolated NC/Nga mice...
  65. ncbi Is hexavalent chromium carcinogenic via ingestion? A weight-of-evidence review
    Deborah M Proctor
    Exponent, Irvine, California 92618, USA
    J Toxicol Environ Health A 65:701-46. 2002
    ..The weight of scientific evidence supports that Cr(VI) is not carcinogenic in humans via the oral route of exposure at permissible drinking-water concentrations...
  66. ncbi Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review
    M Malet-Martino
    Groupe de RMN Biomédicale, Laboratoire des IMRCP, Universite Paul Sabatier, Toulouse, France
    Oncologist 7:288-323. 2002
    ..The literature was analyzed until March 2002. This review is intended to be as exhaustive as possible since it was conceived as a work tool for readers wanting to go further...
  67. ncbi Oral administration of a galactooligosaccharide preparation inhibits development of atopic dermatitis-like skin lesions in NC/Nga mice
    Soichi Tanabe
    Graduate School of Biosphere Science, Hiroshima University, Higashi Hiroshima 739 8528, Japan
    Int J Mol Med 25:331-6. 2010
    ..The results indicate that GOS effectively blocked AD-like skin lesions in the mice by at least partly inducing production of IL-10 and suppressing the production of cytokines such as IL-17, which are involved in skin inflammation...
  68. ncbi Exposure to a low dose of bisphenol A during fetal life or in adulthood alters maternal behavior in mice
    Paola L Palanza
    Department of Evolutionary and Functional Biology, Parma University, Parco Area delle Scienze 11A, 43100 Parma, Italy
    Environ Health Perspect 110:415-22. 2002
    ..The changes seen in maternal behavior may be the result of a direct effect of BPA on the neuroendocrine substrates underlying the initiation of maternal behavior...
  69. ncbi Pharmacokinetics and pharmacodynamics of vildagliptin in patients with type 2 diabetes mellitus
    Yan ling He
    Novartis Institutes for BioMedical Research, Inc, Cambridge, Massachusetts 02139 3584, USA
    Clin Pharmacokinet 46:577-88. 2007
    ..Vildagliptin is a dipeptidyl peptidase IV (DPP-4) inhibitor currently under development for the treatment of type 2 diabetes mellitus...
  70. ncbi Pharmacokinetics of astragaloside iv in beagle dogs
    Qi Zhang
    College of Life Science and Pharmacy, Nanjing University of Technology, Nanjing, People s Republic of China
    Eur J Drug Metab Pharmacokinet 32:75-9. 2007
    ..4%. The plasma protein binding rate of AGS-IV was about 90% within a concentration range of 250-1000 ng.ml(-1). There was no significant species difference regarding the pharmacokinetics of AGS-IV between the rat and the Beagle dog...
  71. ncbi Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (The COMPASS Study)
    Debra J Tompson
    GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex, United Kingdom
    Epilepsia 49:410-7. 2008
    ..To compare the pharmacokinetics (PK) of lamotrigine (LTG) when converting from twice-daily immediate-release (LTG-IR) to once-daily extended-release (LTG-XR) in subjects with epilepsy...
  72. ncbi Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A
    Keon Hyoung Song
    Pharmacokinetics Biopharmaceutics Laboratory, Department of Pharmaceutical Science, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
    Int J Pharm 351:8-14. 2008
    ..The objective of this study was to evaluate the biological activity of AT1002 on enhancing the oral administration of cyclosporin A (CsA)...
  73. ncbi Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma
    Wen Xu
    Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China
    Acta Pharmacol Sin 27:1642-6. 2006
    ..oral gavage with a t(max) of less than 15 min; the extent of absolute bioavailability of oridonin following oral administration was 4.32%, 4.58% and 10.8%...
  74. ncbi The role of corticosteroids in chronic obstructive pulmonary disease
    Peter M A Calverley
    Department of Medicine, Clinical Sciences Centre, University Hospital Aintree, Liverpool L9 7AL, United Kingdom
    Semin Respir Crit Care Med 26:235-45. 2005
    ..Inhaled corticosteroids are not suitable for monotherapy in COPD but can be helpfully combined with an inhaled bronchodilator in patients with symptomatic disease...
  75. ncbi Different impacts of intestinal lymphatic transport on the oral bioavailability of structurally similar synthetic lipophilic cannabinoids: dexanabinol and PRS-211,220
    Pavel Gershkovich
    Department of Pharmaceutics, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Israel
    Eur J Pharm Sci 31:298-305. 2007
    ..The low lymphatic transport of dexanabinol is likely driven by relatively lower affinity to chylomicrons and lower LCT solubility...
  76. ncbi Dose-dependent pharmacokinetics of a new Na+/H+ exchanger inhibitor KR-33028 in rats
    Young Hoon Kim
    Drug Metabolism and Bioanalysis Laboratory, College of Pharmacy, Wonkwang University, Iksan 570 749, Korea
    Biopharm Drug Dispos 28:423-9. 2007
    ..of a new Na(+)/H(+) exchanger inhibitor, KR-33028 was evaluated in rats after intravenous and oral administration. After intravenous administration of KR-33028 (1, 5, 10 and 20mg/kg doses), the systemic clearance (Cl) was ..
  77. ncbi Multiple-dose pharmacokinetics of apricitabine, a novel nucleoside reverse transcriptase inhibitor, in patients with HIV-1 infection
    Pedro Cahn
    Fundacion Huesped, Buenos Aires, Argentina
    Clin Drug Investig 28:129-38. 2008
    ..This study aimed to investigate the multiple-dose pharmacokinetics of apricitabine, a novel deoxycytidine analogue reverse transcriptase inhibitor, in antiretroviral-naive patients with HIV-1 infection...
  78. ncbi Pharmacokinetic and pharmacodynamic interaction for a binary mixture of chlorpyrifos and diazinon in the rat
    C Timchalk
    Center for Biological Monitoring and Modeling, Battelle, Pacific Northwest Division, Richland, WA 99352, USA
    Toxicol Appl Pharmacol 205:31-42. 2005
    ....
  79. ncbi Dose-dependent pharmacokinetics of telithromycin after intravenous and oral administration to rats: contribution of intestinal first-pass effect to low bioavailability
    Joo Hyun Lee
    College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, South Korea
    J Pharm Pharm Sci 10:37-50. 2007
    To evaluate the pharmacokinetics of telithromycin after intravenous and oral administration and to find the reason for incomplete F value (first pass-effect) after intravenous, intraportal, intragastric, and intraduodenal administration ..
  80. ncbi The effects of dose, route, and repeated dosing on the disposition and kinetics of tetrabromobisphenol A in male F-344 rats
    Robert K Kuester
    Department of Pharmacology, College of Medicine, The University of Arizona, Tucson, Arizona 85724 5050, USA
    Toxicol Sci 96:237-45. 2007
    ..About 50% of an oral dose (20 mg/kg) was found in the bile within 2 h. This extensive extraction and metabolism by the liver greatly limits exposure of internal tissues to TBBPA following oral exposures...
  81. ncbi Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease
    Robert B Perni
    Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Cambridge, Massachusetts 02139, USA
    Antimicrob Agents Chemother 50:899-909. 2006
    ..Therefore, the overall preclinical profile of VX-950 supports its candidacy as a novel oral therapy against hepatitis C...
  82. ncbi Enhanced plasma concentration by selective deuteration of rofecoxib in rats
    Frank Schneider
    BiRDS Pharma GmbH, Berlin, Germany
    Arzneimittelforschung 56:295-300. 2006
    ..The substitution of hydrogen by deuterium on the positions 2: 3',4',5' and 6' in BDD-11602 leads to superior oral availability compared to the non-deuterated compound, whereas the COX-2 selectivity is not affected...
  83. ncbi A pharmacokinetic study on Z-(+/-)-2-(1-benzylindole-3-yl-methylene)azabicyclo[2.2.2]octane-3-ol; a novel radio-sensitization agent
    Abeer M Al Ghananeem
    Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536 0082, USA
    Cancer Chemother Pharmacol 60:915-9. 2007
    ..2.2]octane-3-ol (BMABO), a novel radio-sensitization agent, after oral delivery...
  84. ncbi Paroxetine oral solution is bioequivalent to paroxetine tablets--advantages of the solution
    E R W van den Tweel
    Clinical R and D Department, Synthon BV, Nijmegen, The Netherlands
    Int J Clin Pharmacol Ther 45:611-6. 2007
    ..This study was undertaken to compare the pharmacokinetic profiles of paroxetine oral solution and paroxetine tablets in healthy volunteers under fasting conditions...
  85. ncbi In vivo use of the P450 inactivator 1-aminobenzotriazole in the rat: varied dosing route to elucidate gut and liver contributions to first-pass and systemic clearance
    Timothy J Strelevitz
    Pfizer Inc, PGRD, Pharmacokinetics, Dynamics, and Metabolism, Eastern Point Road, Groton, CT 06340, USA
    J Pharm Sci 95:1334-41. 2006
    ..This method should have utility in drug discovery for the identification of factors limiting oral bioavailability...
  86. ncbi Effect of atorvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats
    Soon Pyo Hong
    College of Medicine, Chosun University, Gwangju 501 759, Korea
    Arch Pharm Res 30:90-5. 2007
    ..Pharmacokinetic parameters of diltiazem and desacetyldiltiazem were determined in rats after oral administration of diltiazem (15 mg x kg(-1)) to rats pretreated with atorvastatin (0.5 or 2.0 mg x kg(-1))...
  87. ncbi [The effect of tetramethylpyrazine on the pharmacokinetics of intragastrically administered cyclosporine A in rats]
    Xiao-Lei Liu
    Department of Clinical Pharmacy, The Second Xiangya Hospital of Central South University, Changsha 410011, China
    Yao Xue Xue Bao 41:882-7. 2006
    ..CONCLUSION: It was indicated that the high dose of TMP could apparently increase the intragastric absorption extent of CsA, while almost had no effect on its elimination process...
  88. ncbi Neurotoxicity and toxicokinetics of artelinic acid following repeated oral administration in rats
    Yuanzheng Si
    Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, USA
    Int J Toxicol 26:401-10. 2007
    ..Therefore, the drug exposure time is a key factor in the neurotoxicity induced by AL...
  89. ncbi Pharmacokinetics of tipifarnib after oral and intravenous administration in subjects with advanced cancer
    Steven Zhang
    Johnson and Johnson Pharmaceutical Research and Development, Titusville, New Jersey, USA
    J Clin Pharmacol 46:1116-27. 2006
    ..regimens of tipifarnib that would mimic the systemic exposure obtained after the current twice-daily oral administration of tipifarnib...
  90. ncbi Absorption characteristics of EC-MPS--an enteric-coated formulation of mycophenolic sodium
    W Arns
    Kliniken der Stadt Köln gGmbH, Clinic Merheim, Medical Clinic I, Cologne, Germany
    Int J Clin Pharmacol Ther 44:375-85. 2006
    ..Enteric-coated mycophenolate sodium is an advanced formulation delivering mycophenolic acid (MPA), designed to improve MPA-related upper gastrointestinal adverse events by delaying MPA release until the small intestine...
  91. ncbi The anti-diabetic effects and pharmacokinetic profiles of bis(maltolato)oxovanadium in non-diabetic and diabetic rats
    Shuang Qing Zhang
    School of Pharmaceutical Sciences, Peking University, Beijing 100083, China
    J Pharm Pharmacol 60:99-105. 2008
    ..In conclusion, at the present dosing levels and administration routes, BMOV was effective in lowering plasma glucose levels in diabetic rats. BMOV has a promising outlook as an oral glucose-lowering drug...
  92. ncbi In vivo metabolism and final disposition of a novel nonsteroidal androgen in rats and dogs
    Minoli A Perera
    Division of Pharmaceutics, College of Pharmacy, The Ohio State University, 500 West 12th Ave, Columbus, OH 43210, USA
    Drug Metab Dispos 34:1713-21. 2006
    ..These studies demonstrate that S-4 maintains its promising pharmacokinetic properties in dogs (i.e., high oral bioavailability and linear kinetics) and is largely eliminated via hepatic metabolism by both phase I and phase II enzymes...
  93. ncbi Marked decrease of cyclosporin bioavailability caused by coadministration of ginkgo and onion in rats
    C Y Yang
    Institute of Chinese Pharmaceutical Sciences, China Medical University, Taichung 404, Taiwan, ROC
    Food Chem Toxicol 44:1572-8. 2006
    ..We suggest that concurrent intake of quercetin-rich herbs or foods with cyclosporin are better avoided in order to ensure the efficacy of cyclosporin...
  94. ncbi Increased bioavailability of intravenous versus oral CI-1033, a pan erbB tyrosine kinase inhibitor: results of a phase I pharmacokinetic study
    George R Simon
    Division of Thoracic Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA
    Clin Cancer Res 12:4645-51. 2006
    ..In phase I studies with oral CI-1033, dose-limiting toxicities were primarily gastrointestinal, supporting the exploration of i.v. dosing to achieve optimal drug exposures by increasing bioavailability...
  95. ncbi Double-blind, randomized comparison of the analgesic and pharmacokinetic profiles of controlled- and immediate-release oral oxycodone in cancer pain patients
    J E Stambaugh
    Oncology and Hematology Associates, Woodbury, New Jersey, USA
    J Clin Pharmacol 41:500-6. 2001
    ..Adverse events were similar for both formulations. Following repeat dosing under double-blind conditions, oral CR oxycodone administered q12h provided analgesia comparable to IR oxycodone given qid...
  96. ncbi Pharmacokinetics of etoricoxib in patients with hepatic impairment
    Nancy G B Agrawal
    Department of Drug Metabolism, WP75-200, Merck Research Laboratories, West Point, PA 19486, USA
    J Clin Pharmacol 43:1136-48. 2003
    ..There are no clinical or pharmacokinetic data in patients with severe hepatic insufficiency (Child-Pugh score > 9)...
  97. ncbi The effect of ingestion of ferrous sulfate on the absorption of oral methotrexate in patients with rheumatoid arthritis
    Sean F Hamilton
    Division of Rheumatology, Memorial University of Newfoundland, St. Clare's Mercy Hospital, St. John's, Newfoundland A1C 5B8, Canada
    J Rheumatol 30:1948-50. 2003
    ..CONCLUSION: Our results showed no less absorption of MTX for the placebo group compared to the group that took ferrous sulfate. These results do not support the hypothesis that ferrous sulfate interferes with the absorption of oral MTX...
  98. ncbi Orally disintegrating olanzapine for the treatment of psychotic and behavioral disturbances associated with dementia
    Roy R Reeves
    Department of Psychiatry, University of Mississippi School of Medicine, Jackson, MS, USA
    South Med J 96:699-701. 2003
    ....
  99. ncbi Formulation dependent pharmacokinetics, bioavailability and renal toxicity of a selective cyclooxygenase-1 inhibitor SC-560 in the rat
    Xiao Wei Teng
    Department of Pharmaceutial Sciences, College of Pharmacy, Washington State University, Pullman, Washington 99164-6534, USA
    J Pharm Pharm Sci 6:205-10. 2003
    ..After oral administration of SC-560 in PEG, urine was also collected for 24 h and analysed for urinary sodium, chloride, and ..
  100. ncbi Absorption, bioavailability, and metabolism of para-nonylphenol in the rat
    Trevor Green
    Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, UK
    Regul Toxicol Pharmacol 38:43-51. 2003
    ....
  101. ncbi First human exposure to exogenous single-dose oral estetrol in early postmenopausal women
    M Visser
    Pantarhei Bioscience, Zeist, The Netherlands
    Climacteric 11:31-40. 2008
    ..To evaluate the safety, tolerability, pharmacokinetics and effect on gonadotropins of a single escalating dose of estetrol (E(4))...

Research Grants84

  1. ORAL GENE THERAPY WITH NiMOS FOR INFLAMMATORY BOWEL DISEASE
    Mansoor M Amiji; Fiscal Year: 2010
    ..The PCL matrix is expected to protect the DNA- containing nanoparticles upon oral administration and allow the release to occur in the small and large intestine due to enzymatic degradation with lipases...
  2. Novel Treatment of menopausal hot flushes with an extradiol prodrug
    Istvan Merchenthaler; Fiscal Year: 2009
    ..involved in thermoregulation, (ii) establishing the optimal dose of Q-E2 following its subcutaneous and oral administration using two rat models of hot flush, (iii) provide evidence that the beneficial actions of Q-E2 are mediated ..
  3. Therapeutic Strategies for Environmental Lung Diseases
    James Bonner; Fiscal Year: 2007
    ..In the first aim we will determine whether the oral administration of bis(maltolato)oxovanadium(IV) (BMOV), a bioavailable form of vanadium that is used for diabetes therapy, ..
  4. Glutathione and Lung Fibrosis
    Rui Ming Liu; Fiscal Year: 2010
    ..Importantly, aerosol or oral administration of GSH or N-acetylcysteine (NAC), a precursor of GSH, attenuates lung fibrosis in experimental fibrosis ..
  5. NITROGEN HETEROCYCLES: METABOLIC EFFECTS AND TOXICITY
    Raymond Novak; Fiscal Year: 1993
    ..been reported to increase liver:body weight ratios in rats and to produce fatty degeneration of the liver; oral administration of PY to rats caused hepatic necrosis and the appearance of hepatic nodules...
  6. Oral Vaccination for AIDS Prevention in Rhesus Macaques
    Anna Aldovini; Fiscal Year: 2010
    ..micro particle formulation of a DNA-MVA SIV vaccine stimulates broader mucosal and systemic responses after oral administration. 3. To evaluate which of the two above regimens provides the best protection from vaginal SIV challenge. 4...
  7. Preventing NIHL by enhancing glutathione pathways
    Richard Kopke; Fiscal Year: 2002
    ..The long-term objective is to develop agents for oral administration in clinical populations...
  8. IMPACT OF INTESTINAL DYSFUNCTION ON ANTIRETROVIRAL THERAPY IN INDIA
    RITA CAROLINE ISAAC; Fiscal Year: 2010
    ..of initiation of HAART using the tests d-xylose and mannitol:lactulose excretion in the urine following oral administration of these sugars...
  9. Ethnic Differences in Survival after Childhood ALL
    Smita Bhatia; Fiscal Year: 2009
    ..Treatment of ALL requires a maintenance phase of approximately two years composed of oral administration of antimetabolites [6-Mercaptopurine (6MP) and methotrexate (MTX)] in order to achieve durable remissions...
  10. IMMUNOREGULATION AND PATHOLOGY OF CHRONIC-RELAPSING EAE
    Stephen Miller; Fiscal Year: 2004
    ..In comparison to tolerance induced by the i.v. or oral administration of soluble peptide, tolerance induced by Ag-SP was shown to be highly effective for prevention and ..
  11. Intervention of Pancreatic Oncogenic Pathways with Dietary Tocotrienol
    Mokenge P Malafa; Fiscal Year: 2010
    ..shows accumulation of bioactive concentrations of 4-tocotrienol in the pancreatic tissue of mice following oral administration. These findings combined with its superior efficacy and safety, make 4-tocotrienol a promising anticancer ..
  12. Intervention of Pancreatic Oncogenic Pathways with Dietary Tocotrienol
    Mokenge Malafa; Fiscal Year: 2009
    ..shows accumulation of bioactive concentrations of 4-tocotrienol in the pancreatic tissue of mice following oral administration. These findings combined with its superior efficacy and safety, make 4-tocotrienol a promising anticancer ..
  13. CDP-choline: Mechanisms in Cerebral Ischemia
    RAO ADIBHATLA; Fiscal Year: 2006
    ..It has now been realized that oral administration in USA trials was inappropriate and new Phase III trials will soon be undertaken...
  14. Novel Puerarin Analogs with Anti-Diabetic Activity
    NICHOLAS CAIRNS; Fiscal Year: 2007
    ..p. or oral administration. Puerarin is rapidly absorbed from the intestine without metabolism and appears to exert its hypoglycemic ..
  15. Stampidine: A Novel Broad-Spectrum Antiviral Agent
    Taracad Venkatachalam; Fiscal Year: 2003
    ..Pharmacokinetic and toxicity studies of STAMP conducted in mice, rats, cats, and dogs following oral administration of formulated GMP-grade STAMP (25-100 mg/kg/day) as hard gelatin capsules showed favorable pharmacokinetics...
  16. Development of Novel Therapies or Methamphetamine Abuse
    Linda Dwoskin; Fiscal Year: 2009
    ..evaluations to assess their drugability, as well as their ability to decrease methamphetamine SA following oral administration. Our goal by the end of the 2nd year of the Competitive Revision Application is to have identified a ..
  17. Therapeutic Use of Heme Analogs: Absorption in Intestine
    David Stevenson; Fiscal Year: 2009
    ..to logically extend our findings from the previous funded proposal to investigate the efficacy of the oral administration of tin mesoporphyrin (SnMP), other selected heme analogs, and non-porphyrin inhibitors of HO to the heme-..
  18. Evaluation of CYP24 as a Target for Enhancing Vitamin D*
    Donald Trump; Fiscal Year: 2006
    ..on high exposure to calcitriol which may be limited by: [1] apparent "saturable absorption" following oral administration, which may depend on induction of mucosal and hepatic metabolism of calcitriol by CYP24, the enzyme most ..
  19. Therapeutic Use of Heme Analogs: Absorption in Intestine
    David Stevenson; Fiscal Year: 2009
    ..to logically extend our findings from the previous funded proposal to investigate the efficacy of the oral administration of tin mesoporphyrin (SnMP), other selected heme analogs, and non-porphyrin inhibitors of HO to the heme-..